The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kotov A.S.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Rudakova I.G.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo, Moskva

Epilepsy in elderly

Authors:

Kotov A.S., Rudakova I.G.

More about the authors

Read: 1391 times


To cite this article:

Kotov AS, Rudakova IG. Epilepsy in elderly. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(7):4‑7. (In Russ.)

Recommended articles:
Personality profile caused by epilepsy acco­rding to the «Big Five» model. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):16-21
Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19
Abse­nce status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56
Clinical mani­festation of apical hype­rtrophic cardiomyopathy by syncope in the elde­rly. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):237-243

References:

  1. Administration on Aging, U.S. Department of Health and Human Services. A Profile of Older Americans. Washington, DC 2005.
  2. Brodie M.J., Overstall P.W., Giorgi L.Multicentre, double-blind randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37: 1: 81-87.
  3. Cusack B.J.Drug metabolism in the elderly. J Clin Pharmacol 1988; 28: 571-576.
  4. Daywling S., Crome P.Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet 1989; 17: 236-263.
  5. Greenblatt D.J.Reduced serum albumin concentrations in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriat Soc 1979; 27: 20-22.
  6. Hauser W.A., Hesdorffer D.C.Eds. Epilepsy, Frequency, Causes and Consequences. New York: Demos 1990; 1-51.
  7. Hauser W.A.Seizure disorders: the changes with age. Epilepsia 1992; 33: Suppl 4: 6-14.
  8. Hauser W.A., Annegers J.F., Rocca W.A.Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996; 71: 576-586.
  9. Hussein Z., Posner J.Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Br J Clin Pharmacol 1997; 43: 457-465.
  10. Kijsanayotin P. et al.Phenytoin doses and CYP 2C9 and 2C19 mutations. Platform presentation AAN. Neurology 2007; 68: Suppl 1: 212.
  11. Levy R.H., Bishop F., Streeter A.J. et al.Explanation and prediction of drug interactions with topiramate using a CYP450 inhibition spectrum. In: Cereghino J. ed. Annual Meeting of the American Epilepsy Society. Baltimore: Lippincott-Raven 1995; 47.
  12. Perucca E., Berlowitz D., Birnbaum A. et al.Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006; 68: Suppl 1: 49-63.
  13. Pugh M.J.V., Cramer J., Knoefel J. et al.Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J Am Geriat Soc 2003; 52: 417-422.
  14. Rowan A.J., Ramsay R.E., Collins J.F. et al.New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64: 11: 1868-1873.
  15. Rowe J.W., Andres R., Tobin J.D. et al.The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-163.
  16. Sachdeo R.C., Sachdeo S.K., Walker S.A. et al.Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1996; 37: 774-780.
  17. Tiula E., Neuvonen P.J.Antiepileptic drugs and alpha-1 acid glycoprotein. N Engl J Med 1982; 307: 1148.
  18. Verbeeck R.K., Cardinal J.A., Wallace S.M.Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 1984; 27: 91-97.
  19. Wallace S.M., Verbeeck R.K.Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 1987; 12: 41-72.
  20. Wynne H.A., Cope L.H., Mutch E. et al.The effect of age on liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
  21. Yuen A.W., Land G., Weatherley B.C. et al.Sodium valproate acutely inhibits lamotrigine metabolism. Br J Clin Pharmacol 1992; 33: 511-513.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.